CBUS
Price
$1.57
Change
-$0.02 (-1.26%)
Updated
Sep 11 closing price
Capitalization
121.14M
54 days until earnings call
Intraday BUY SELL Signals
DNLI
Price
$21.09
Change
-$0.31 (-1.45%)
Updated
Sep 11 closing price
Capitalization
3.37B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CBUS vs DNLI

CBUS vs DNLI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CBUS vs. DNLI commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a StrongBuy and DNLI is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.37B) has a higher market cap than CBUS($121M). DNLI YTD gains are higher at: 27.741 vs. CBUS (-9.770). CBUS has higher annual earnings (EBITDA): -57.5M vs. DNLI (-526.81M). DNLI has more cash in the bank: 710M vs. CBUS (20.4M). DNLI (32.2M) and CBUS (32.7M) have identical debt. CBUS has higher revenues than DNLI: CBUS (4.35M) vs DNLI (3.6M).
CBUSDNLICBUS / DNLI
Capitalization121M3.37B4%
EBITDA-57.5M-526.81M11%
Gain YTD-9.77027.741-35%
P/E RatioN/AN/A-
Revenue4.35M3.6M121%
Total Cash20.4M710M3%
Total Debt32.7M32.2M102%
FUNDAMENTALS RATINGS
CBUS vs DNLI: Fundamental Ratings
CBUS
DNLI
OUTLOOK RATING
1..100
6050
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6254
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBUS's Valuation (47) in the null industry is somewhat better than the same rating for DNLI (90) in the Biotechnology industry. This means that CBUS’s stock grew somewhat faster than DNLI’s over the last 12 months.

CBUS's Profit vs Risk Rating (100) in the null industry is in the same range as DNLI (100) in the Biotechnology industry. This means that CBUS’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's SMR Rating (98) in the Biotechnology industry is in the same range as CBUS (100) in the null industry. This means that DNLI’s stock grew similarly to CBUS’s over the last 12 months.

DNLI's Price Growth Rating (54) in the Biotechnology industry is in the same range as CBUS (62) in the null industry. This means that DNLI’s stock grew similarly to CBUS’s over the last 12 months.

DNLI's P/E Growth Rating (99) in the Biotechnology industry is in the same range as CBUS (100) in the null industry. This means that DNLI’s stock grew similarly to CBUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBUSDNLI
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CBUS: $1.57 vs. DNLI: $21.09)
Brand notoriety: CBUS and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 26% vs. DNLI: 83%
Market capitalization -- CBUS: $121.14M vs. DNLI: $3.37B
CBUS [@Biotechnology] is valued at $121.14M. DNLI’s [@Biotechnology] market capitalization is $3.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 0 FA rating(s) are green while DNLI’s FA Score has 0 green FA rating(s).

  • CBUS’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, CBUS is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 3 bullish TA indicator(s).

  • CBUS’s TA Score: 4 bullish, 5 bearish.
  • DNLI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CBUS is a better buy in the short-term than DNLI.

Price Growth

CBUS (@Biotechnology) experienced а -1.26% price change this week, while DNLI (@Biotechnology) price change was -5.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CBUS is expected to report earnings on Nov 05, 2026.

DNLI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CBUS
Daily Signal:
Gain/Loss:
DNLI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QMMY26.510.15
+0.58%
FT Vest Nasdaq-100 Mod Buffr ETF - May
PBAU31.960.11
+0.35%
PGIM S&P 500 Buffer 20 ETF - Aug
FEP59.560.17
+0.29%
First Trust Europe AlphaDEX® ETF
XOP195.720.25
+0.13%
SttStrtSPDRS&POil&GasExplor&ProdtnETF
SBB23.20-0.13
-0.56%
ProShares Short SmallCap600

CBUS and

Correlation & Price change

A.I.dvisor tells us that CBUS and ELDN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBUS and ELDN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
-0.95%
ELDN - CBUS
32%
Poorly correlated
N/A
QSI - CBUS
31%
Poorly correlated
+0.12%
DNLI - CBUS
31%
Poorly correlated
-1.45%
TWST - CBUS
30%
Poorly correlated
+0.29%
ABOS - CBUS
29%
Poorly correlated
+2.10%
More